نتائج البحث 71-80 من 15892 لعملية البحث عن B cell lymphomas
... B-Cell Lymphoma (DLBCL). Rochester, Minn. The purpose of ths study is to find out more about the side effects of two new drug combinations for lymphoma, TTI ...
... B-cell Lymphoma (R/R DLBCL). Rochester, Minn. Study B9991011 is a multi-center, international, randomized, open label, 2 component (Phase 1b followed by ...
gkin's lymphoma, Hodgkin lymphoma, Hairy cell leukemia, Cutaneous t-cell lymphoma, Cutaneous b-cell lymphoma, Diffuse large b-cell lymphoma, Follicular lymphoma.
... B-cell lymphoma 2 (BCL2) inhibitor. MC1733, Phase I Trial of Intratumoral Administration of a Measles Virus Derivative Expressing the Helicobacter pylori ...
... lymphoma who are in clinical remission. Axicabtagene Ciloleucel versus Standard of Care Therapy as First-Line Therapy in High-Risk Large B-Cell Lymphoma.
... B-cell lymphoma 2 (BCL2) inhibitor. MC1733, Phase I Trial of Intratumoral ... A Study to Evaluate Immune and Hematopoietic Cell Assessment in Clonal B Cell ...
Axicabtagene Ciloleucel versus Standard of Care Therapy as First-Line Therapy in High-Risk Large B-Cell Lymphoma. Rochester, Minn., Mankato, Minn., La Crosse ...
... B) of CA-4948 in patients with RR NHL with and without myeloid ... B-cell lymphoma 2 (BCL2) inhibitor. MC1733, Phase I Trial of Intratumoral ...
لا تُقدم Mayo Clinic الدعم للشركات أو المنتجات المُعلَّن عنها هنا. لكن تدعم العائدات الإعلانية رسالتنا غير الربحية.
تحقق من هذه الكتب الأكثر مبيعًا والعروض الخاصة على الكتب والنشرات الإخبارية من Mayo Clinic Press.
تساهم التبرّعات، وهي قابلة للخصم الضريبي، في دعم آخر التطورات في الأبحاث وطرق الرعاية لإحداث نقلة نوعية في الطب.